It starts July 1, 2026 and is set to run through Dec
Mabilleau G, Pereira M, Chenu C
Isaksson, H., Rakha, A., Andersson, R., Fredriksson, H., Olsson, J., & Aman, P
has received honoraria from Boehringer Ingelheim, Eli Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, AbbVie, Janssen, Bayer, Prometic, Bristol Myers Squibb, Maze, Gilead, CSL-Behring, Otsuka, Novartis, Youngene and Novo Nordisk and has received operational funding for clinical trials from Boehringer Ingelheim, Eli Lilly, Merck, Janssen, Sanofi, AstraZeneca, CSL-Behring and Novo Nordisk
Its not yet known whether GLP-1s can flip this switch, but there is a medical precedent for this, Schwartz says
SHAWN STEVENSON: Right